ID 405015353 · FY 2018–2021 · 4 years
კომპანიის ძირითად საქმიანობას წარმოადგენს წარმოადგენს სამედიცინო პრეპარატის წარმოებას და რეალიზაციას.
Bars are revenue on the left axis; lines are EBITDA and net margin on the right.
| Ratio | 2018 | 2019 | 2020 | 2021 |
|---|---|---|---|---|
| Margins | ||||
| Gross Margin | 24.7% | 18.4% | 5.9% | 19.6% |
| EBITDA Margin | 17.1% | -13.6% | -7.4% | -54.4% |
| EBITDAR | 423 | -90 | -148 | -323 |
| EBITDAR Margin | 19.0% | -8.4% | -5.9% | -54.4% |
| EBIT Margin | 17.1% | -13.6% | -7.4% | -54.5% |
| Net Profit Margin | 16.3% | -3.7% | -8.4% | -10.7% |
| Operating Expense % of Sales | 7.6% | 32.0% | 13.3% | 74.0% |
| Returns | ||||
| Return on Assets (ROA) | 8.8% | -0.8% | -2.6% | -0.8% |
| Return on Equity (ROE) | 26.2% | -2.9% | -16.5% | -5.7% |
| ROIC [EBIT / Invested Capital] | 48.2% | N/A | -5.4% | -10.7% |
| Leverage & liquidity | ||||
| Debt-to-Assets | 0.0% | 0.0% | 27.2% | 22.5% |
| Debt-to-Equity | 0.00x | 0.00x | 1.74x | 1.71x |
| Debt-to-EBITDA | 0.00x | N/A | N/A | N/A |
| Equity-to-Assets | 33.6% | 26.5% | 15.6% | 13.2% |
| Net Debt | -598 | -1,642 | 2,207 | 1,901 |
| Cash & Equivalents | 598 | 1,642 | 33 | 5 |
| Total Debt | N/A | N/A | 2,239 | 1,906 |
| Efficiency & working capital | ||||
| Inventory Turnover | N/A | 2.92x | 7.43x | 1.14x |
| Days Inventory Outstanding (DIO) | N/A | 125.1 | 49.1 | 320.2 |
| Receivables Turnover | 0.85x | 0.40x | 0.83x | 0.13x |
| Days Sales Outstanding (DSO) | 430.4 | 906.1 | 442.3 | 2760.4 |
| Payables Turnover | 0.61x | 0.23x | 2.43x | 0.79x |
| Days Payable Outstanding (DPO) | 594.1 | 1560.9 | 149.9 | 463.6 |
| Cash Conversion Cycle | -163.7 days | -529.7 days | 341.5 days | 2616.9 days |
| Asset Turnover | 0.54x | 0.21x | 0.31x | 0.07x |
| Cash flow & dividends | ||||
| Operating Cash Flow | N/A | N/A | N/A | N/A |
| Free Cash Flow (OCF − Capex proxy) | N/A | N/A | N/A | N/A |
| Cash Conversion (OCF / EBITDA) | N/A | N/A | N/A | N/A |
| Dividends Declared | N/A | N/A | N/A | N/A |
| Dividend Payout Ratio | N/A | N/A | N/A | N/A |
Money rows — EBITDAR, net debt, cash, total debt, operating and free cash flow, dividends declared — are in ₾ '000. Margins, returns and payout are percentages; turnover and leverage are multiples; DIO/DSO/DPO are days. Hover a metric name for its definition.
Shareholders, directors and group links from the companyinfo.ge public register — as filed, so stakes need not sum to 100% where a holding is undisclosed.
Ownership & directors from companyinfo.ge (public corporate registry).
Companies sharing this sub-sector, ranked by how close their latest revenue is to this one — not a curated comp set.